Sign in

CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company

Verastem, Inc.

Sign in to watch
Ticker
VSTM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
operating
EIN
273269467
Phone
(781) 292-4200
Business address
117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
  1. 4 Grant or award Director acquired 8,333 shares (grant or award)
  2. 4 Grant or award Director acquired 8,333 shares (grant or award)
  3. 4 Open-market sale Chief Financial Officer sold 67 shares at $3.16 ($212)
  4. 4 Grant or award Director acquired 8,333 shares (grant or award)
  5. 4 Open-market sale Director sold 414 shares at an average $3.40 ($1,408)
  6. 4 Grant or award Director acquired 8,333 shares (grant or award)
  7. 4 Open-market sale President and CEO sold 427 shares at an average $3.37 ($1,439)
  8. 4 Open-market sale Director sold 928 shares at an average $3.39 ($3,145)
  9. 4 Grant or award Director acquired 8,333 shares (grant or award)
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. 8-K Event Regulation FD disclosure · Other events
  12. 8-K Event Shareholder vote results · Regulation FD disclosure · Other events
  13. 10-Q Report Quarterly Report
  14. DEF 14A Proxy Proxy Statement
  15. 8-K Event Regulation FD disclosure
  16. 4 Open-market sale Chief Financial Officer sold 6 shares at $10.87 ($65)
  17. 4 Open-market sale Chief Financial Officer sold 25 shares at $12.02 ($301)
  18. 4 Open-market sale Chief Financial Officer sold 55 shares at $11.07 ($609)
  19. 4 Open-market sale Director sold 413 shares at an average $10.61 ($4,380)
  20. 4 Open-market sale President and CEO sold 426 shares at an average $10.57 ($4,502)

Page 13 of 53 · 1,058 filings